|
Volumn 33, Issue 2, 2013, Pages 115-117
|
What evidence is required for drug exposure to be causally associated with adverse events? The case for case reports published in pharmacotherapy
|
Author keywords
Adverse events; Case reports; Postmarketing surveillance
|
Indexed keywords
DRUG;
NEW DRUG;
SEROTONIN UPTAKE INHIBITOR;
ADVERSE DRUG REACTION;
ARTICLE;
CASE REPORT;
DELIRIUM;
DEPRESSION;
DISEASE PREDISPOSITION;
DRUG EXPOSURE;
DRUG HYPERSENSITIVITY;
DRUG RESEARCH;
DRUG RESPONSE;
DRUG SURVEILLANCE PROGRAM;
EVIDENCE BASED MEDICINE;
HEART ATRIUM FIBRILLATION;
HOSPITAL ADMISSION;
HUMAN;
INCIDENCE;
KIDNEY CLEARANCE;
KIDNEY DISEASE;
MEDICAL LITERATURE;
MENTAL DISEASE;
PHARMACOEPIDEMIOLOGY;
PRACTICE GUIDELINE;
PRESCRIPTION;
PUBLICATION;
RISK BENEFIT ANALYSIS;
SUICIDAL BEHAVIOR;
SYMPTOM;
TOXIC HEPATITIS;
ADVERSE DRUG REACTION REPORTING SYSTEMS;
EDITORIAL POLICIES;
EVIDENCE-BASED MEDICINE;
HUMANS;
PHARMACEUTICAL PREPARATIONS;
|
EID: 84875468433
PISSN: 02770008
EISSN: None
Source Type: Journal
DOI: 10.1002/phar.1249 Document Type: Article |
Times cited : (3)
|
References (11)
|